Bifogade filer
Lipum receives loan commitment of SEK 20 million
Prenumeration
Du har en aktiv prenumeration.
Prenumerera på pressmeddelanden från Lipum via email.
Du prenumererar på följande språk.
Välj vilka språk du vill prenumerera på.
Modular Finance AB kommer att hantera vissa av dina personuppgifter om du väljer att prenumerera. Mer information om vår personuppgiftshantering finns här.
Beskrivning
| Land | Sverige |
|---|---|
| Lista | First North Stockholm |
| Sektor | Hälsovård |
| Industri | Läkemedel & Handel |
2024-05-06 09:00:00
Lipum AB (publ) has signed an agreement with Flerie Invest AB including a loan commitment of SEK 20 million. The agreement which has been signed on market terms, enters into force on 1 June 2024, has a term of 12 months and runs without collateral.
"We are in a very intense phase with the completion of the clinical phase 1 study as well as we intend to start the planning of a phase 2 study. At the same time, we run several preclinical initiatives where we need flexibility in optimizing the execution. With this loan commitment, we get a security to carry out the activities without unnecessary delay. I am very pleased with the support we receive from our major shareholder Flerie Invest ", says Ola Sandborgh, CEO of Lipum.